Prospective registration and outcome-reporting bias in randomized controlled trials of eczema treatments: A systematic review

Journal of Investigative Dermatology

Volumn 132, Issue 12, 2012, Pages 2727-2734

  Nankervis, Helen ^a   Baibergenova, Akerke ^b   Williams, Hywel C ^a   Thomas, Kim S ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PIMECROLIMUS; PROBIOTIC AGENT;

ARTICLE; ATOPIC DERMATITIS; BIBLIOGRAPHIC DATABASE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE SEVERITY; ECZEMA; EMBASE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; MEDLINE; OUTCOME ASSESSMENT; OUTCOME REPORTING BIAS; POST HOC ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SYSTEMATIC REVIEW (TOPIC); TREATMENT INDICATION;

EID: 84870564237     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.231     Document Type: Article

References (32)

1. Armstrong AW, Kim RH, Idriss NZ et al. (2011) Online video improves clinical outcomes in adults with atopic dermatitis: a randomized controlled trial. J Am Acad Dermatol 64:502-7
2. Bangert C, Strober BE, Cork M et al. (2011) Clinical and cytological effects of pimecrolimus cream 1% after resolution of active atopic dermatitis lesions by topical corticosteroids: a randomized controlled trial. Dermatology 222:36-48
3. Brenninkmeijer EE, Spuls PI, Lindeboom R et al. (2010) Excimer laser versus clobetasol propionate 005 ointment in prurigo form of atopic dermatitis: a randomized controlled trial, a pilot. Br J Dermatol 163:823-31
4. Chalmers I (1990) Underreporting research is scientific misconduct. JAMA 263:1405-8 (Pubitemid 20069949)
5. Chalmers I, Glasziou P (2009) Avoidable waste in the production and reporting of research evidence. Lancet 374:86-9
6. Chan AW, Altman DG (2005) Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors. BMJ 330:753
7. Chan AW, Hró bjartsson A, Haahr MT et al. (2004) Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA 291:2457-65 (Pubitemid 38669189)
8. DeAngelis CD, Drazen JM, Frizelle FA et al. (2004) International Committee of Medical Journal Editors. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. JAMA 292:1363-4 (Pubitemid 39223230)
9. Dwan K, Altman DG, Arnaiz JA et al. (2008) Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLOS One 3:e3081
10. Faure H, Hrynaszkiewicz I (2011) The ISRCTN register: achievements and challenges 8 years on. J Evid Based Med 4:188-92
11. Foelster Holst R, Reitamo S, Yankova R et al. (2010) The novel protease inhibitor SRD441 ointment is not effective in the treatment of adult subjects with atopic dermatitis: results of a randomized, vehiclecontrolled study. Allergy 65:1594-9
12. Frankel A, Sohn A, Patel RV et al. (2011) Bilateral comparison study of pimecrolimus cream 1% and a ceramide-hyaluronic acid emollient foam in the treatment of patients with atopic dermatitis. J Drugs Dermatol 10:666-72
13. Gambichler T, Othlinghaus N, Tomi NS et al. (2009) Medium-dose ultraviolet (UV) A1 versus narrowband UVB phototherapy in atopic eczema: a randomized crossover study. Br J Dermatol 160:652-8
14. Higgins JPT, Altman DG (2008) Chapter 8: assessing risk of bias in included studies. In Higgins JPT, Green S (eds). Cochrane Handbook for Systematic Reviews of Interventions. John Wiley & Sons: Chichester, UK
15. Higgins JPT, Altman DG, Sterne JAC (2011) Chapter 8: assessing risk of bias in included studies. In Higgins JPT, Green S, (eds). Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration Version 5.1.0 (updated March 2011). Available from www.cochranehandbook. org
16. Hoeger PH, Lee KH, Jautova J et al. (2009) The treatment of facial atopic dermatitis in children who are intolerant of, or dependent on, topical corticosteroids: a randomized, controlled clinical trial. Br J Dermatol 160:415-22
17. Hon KL, Leung TF, Ng PC et al. (2007) Efficacy and tolerability of a Chinese herbal medicine concoction for treatment of atopic dermatitis: a randomized, double-blind, placebo-controlled study. Br J Dermatol 157:357-63 (Pubitemid 47083830)
18. Huang JT, Abrams M, Tlougan B et al. (2009) Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity. Pediatrics 123:e808-14
19. Kirkham JJ, Dwan KM, Altman DG et al. (2010) The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews. BMJ 340:c365
20. Lefebvre C, Manheimer E, Granville J (2009) Chapter 6: searching for studies. In Cochrane Handbook of Interventions. The Cochrane Collaboration Version 5.0.2 (updated September 2009). Available from www. cochrane-handbook. org
21. Mathieu S, Boutron I, Moher D et al. (2009) Comparison of registered and published primary outcomes in randomized controlled trials. JAMA 302:977-84
22. Moore EJ, Williams A, Manias E et al. (2009) Eczema workshops reduce severity of childhood atopic eczema. Australas J Dermatol 50:100-6
23. Murrell DF, Calvieri S, Ortonne JP et al. (2007) A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids. Br J Dermatol 157:954-9 (Pubitemid 47583533)
24. Ormerod AD, Williams HC (2005) Compulsory registration of trials. Br J Dermatol 152:859-60
25. Peserico A, Städtler G, Sebastian M et al. (2008) Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: a multicentre, randomized, double-blind, controlled study. Br J Dermatol 158:801-7 (Pubitemid 351415740)
26. Ruer-Mulard M, Aberer W, Gunstone A et al. (2009) Twice-daily versus oncedaily applications of pimecrolimus cream 1% for the prevention of disease relapse in pediatric patients with atopic dermatitis. Pediatr Dermatol 26:551-8
27. Schmitt J, Schäkel K, Fölster-Holst R et al. (2010) Prednisolone versus ciclosporin for severe adult eczema. An investigator- initiated double-blind placebo-controlled multicentre trial. Br J Dermatol 162:661-8
28. Thomas KS, Dean T, O'Leary C et al. (2011) A randomised controlled trial of ion-exchange water softeners for the treatment of eczema in children. PLoS Med 8:e1000395
29. Tzaneva S, Kittler H, Holzer G et al. (2010) 5-Methoxypsoralen plus ultraviolet (UV) A is superior to medium-dose UVA1 in the treatment of severe atopic dermatitis: a randomized crossover trial. Br J Dermatol 162:655-60
30. van der Aa LB, Heymans HS, van Aalderen WM et al. (2010) Effect of a new synbiotic mixture on atopic dermatitis in infants: a randomizedcontrolled trial. Clin Exp Allergy 40:795-804
31. Williams HC, Stern RS (2005) Prospective trials registration. J Invest Derm 124:vii
32. Wirén K, Nohlga°rd C, Nyberg F et al. (2009) Treatment with a barrierstrengthening moisturizing cream delays relapse of atopic dermatitis: a prospective and randomized controlled clinical trial. J Eur Acad Dermatol Venereol 23:1267-72